
Discover our medicines
Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.

Explore our science
Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.

Learn about our impact
Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective.

Official partner of the Eurovision Song Contest 2025
Between May 10-17, 2025, Basel will host the Eurovision Song Contest and we are excited to be an official partner.
Latest news
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with SMA
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting

Novartis in Society Integrated Report 2024
Read more about our performance against our business, environmental, social and governance (ESG) priorities in the Novartis in Society Integrated Report 2024.